Desenvolvimento tecnológico da biotecnologia para a saúde no Brasil

Abstract

Objective of the study: This study aims to analyze the technological development of health biotechnology in Brazil in the period from 2007 to 2016.Methodology: The research methodology was based on a quantitative approach with the application of statistical methods aligned with patent analysis. Data collection was carried out on the institutional page of the National Institute of Industrial Property (INPI). The health biotechnology patents were classified according to the definitions presented by the Biotechnology Development Policy (PDB).Originality/Relevance: This study brings new contributions to the literature on the technological development of biotechnology when dealing with the sectoral level.Main results: The results obtained showed a total of 503 patents granted, with applications that mostly involve human health (70%). The development of drugs for the treatment of metabolic or endocrinological diseases is notorious, while vaccines have greater applications in the prevention of veterinary diseases. Also, patent ownership belongs mostly to large companies in developed countries.Theoretical/methodological contributions: The study deepened the understanding of the technological development of biotechnology in Brazil using patent indicators and allowed us to understand this dynamic in the sectorial context involving health.Social/managerial contributions: The statistics of patents in health biotechnology can assist policymakers in practices aimed at promoting research, development, and innovation activities with applications in health.